U.S. Medical Equipment Stock News

In its most recent quarter, Hartford Insurance Group reported US$7.23 billion in revenue, a 6.1% year-on-year increase that exceeded analysts’ expectations, but earnings per share and book value per share fell short of forecasts. This combination of strong top-line momentum and weaker profitability metrics raises questions about how effectively Hartford is converting growth into shareholder value. We'll now examine how Hartford's strong revenue beat but weaker earnings metrics could...

Insiders who purchased US$3.76m worth of Mercer International Inc. ( NASDAQ:MERC ) shares over the past year recouped...

Venture Global, Inc. ( NYSE:VG ) just released a solid earnings report, and the stock displayed some strength. Despite...

From what we can see, insiders were net buyers in TransAct Technologies Incorporated's ( NASDAQ:TACT ) during the past...

We wouldn't blame Adeia Inc. ( NASDAQ:ADEA ) shareholders if they were a little worried about the fact that Kevin...

Some Monster Beverage Corporation ( NASDAQ:MNST ) shareholders may be a little concerned to see that the Chief...

We'd be surprised if Royal Gold, Inc. ( NASDAQ:RGLD ) shareholders haven't noticed that the Senior VP & General...

Some Teradata Corporation ( NYSE:TDC ) shareholders may be a little concerned to see that the President, Stephen...

Investors weren't pleased with the recent soft earnings report from Waters Corporation ( NYSE:WAT ). We did some...

Why EagleRock Land Moved and What It Means for Investors EagleRock Land (EROK) drew investor attention after a single day move of 6.7%, with the stock closing at US$23. That shift puts a spotlight on how the company’s land and water assets are currently being valued. See our latest analysis for EagleRock Land. The 6.7% 1 day share price return comes on top of a 5.3% year to date share price return, which suggests that momentum in EagleRock Land has recently been building rather than...

For readers wondering whether Qorvo at around US$94 per share still offers value, or if the easier gains have already been realized, this article breaks down what the current price might be implying about the stock. The stock has returned 0.9% over the past week and 15.0% over the past month, with a 9.2% return year to date. The 1-year return sits at 19.5%, while the 3- and 5-year returns reflect declines of 2.0% and 47.3% respectively. These figures can influence how investors think about...

Wondering whether Insight Enterprises at US$90.59 is offering value or just noise at the current price? This article walks you through what the numbers are actually saying about the stock. The share price has risen 2.7% over the last 7 days and 18.5% over the last 30 days, although it is still down 33.0% over the past year and 12.1% over 5 years. This combination of moves can change how you think about both risk and potential reward. These moves are drawing more attention to Insight...

Wondering whether Impinj at around US$139 per share still offers value or if the market has already priced in the story? This article walks through what the current price might be implying. The stock has been volatile recently, with a 7 day return that declined 9.4%, a 30 day return of 24.1%, a year to date return that declined 22.5% and a 1 year return of 13.0%, while the 3 year return is 41.2% and the 5 year return is 174.2%. These moves come as investors continue to reassess where Impinj...

In the first quarter ended March 31, 2026, Calumet, Inc. reported sales of US$1,029.7 million, up from US$993.9 million a year earlier, while net loss widened to US$317 million from US$162 million. This combination of higher revenue but a much larger loss highlights the pressure on profitability even as Calumet grows its top line. Next, we’ll examine how Calumet’s sharply higher quarterly net loss may influence its existing investment narrative and risk profile. Invest in the nuclear...

In the past week, Figma reported first-quarter 2026 results showing revenue rising to US$333.44 million from US$228.2 million a year earlier, while moving from a net income of US$8.61 million to a net loss of US$142.4 million and issuing higher revenue guidance for the second quarter and full year. The company attributed this combination of faster revenue growth and weaker profitability to rapid adoption of its AI-powered design tools and expanded enterprise usage, highlighting how AI is...

OneStream (OS) is back in focus after announcing an expanded partnership with Microsoft that commits new multi year investment to scale Azure based AI infrastructure and embed its finance focused AI tools deeper into Microsoft’s ecosystem. See our latest analysis for OneStream. The stock’s recent moves suggest momentum has been building, with a 90 day share price return of 30.51% and a 1 year total shareholder return of 32.74% at a last close of US$24.0, as investors weigh the expanded...

Wondering if Adient at around US$20.64 is a bargain or a value trap? This article walks through what the current price might really imply about the stock. The share price has fallen 6.7% over the last week and 5.3% over the last month, yet it is still up 8.4% year to date and 32.8% over the past year, while the 3 year and 5 year returns show declines of 42.3% and 56.7% respectively. These swings have kept Adient on investors' radars, with the longer term share price performance contrasting...

Pursuit Attractions and Hospitality (PRSU) drew investor attention after reporting first quarter earnings, with revenue of US$51.64 million and a narrowed net loss, while reaffirming full year 2026 revenue guidance of about US$465 million. See our latest analysis for Pursuit Attractions and Hospitality. The reaffirmed 2026 revenue guidance comes after a strong run in the stock, with a 90 day share price return of 15.72% and a 1 year total shareholder return of 45.80%, suggesting momentum has...

Wondering whether Adaptive Biotechnologies at US$12.71 is priced attractively or not? This article unpacks what that tag could really mean for you. The stock has been under pressure in the short term, with the share price down 6.1% over the past week, 12.2% over the past month, and 20.1% year to date, even though the 1 year return is 38.2% and the 3 year return is 99.5% against a 65.3% decline over 5 years. Recent company specific news has put the focus back on how the business is positioned...

In May 2026, Aurinia Pharmaceuticals reported first-quarter 2026 results showing revenue of US$77.71 million and net income of US$34.36 million, alongside higher basic and diluted earnings per share than a year earlier. The company also reiterated its 2026 revenue guidance, signaling management’s continued confidence in the business outlook following the stronger quarterly profitability. We’ll now explore how this reaffirmed 2026 revenue outlook and improved quarterly earnings shape...

Wondering if Ross Stores at around US$211 a share is still worth your attention, or if the easy gains are already behind it? The stock is up 15.5% year to date and 38.2% over the past year, even though it has slipped 1.6% over the last week and 7.3% over the last month. Recent coverage has focused on Ross Stores as a long running off price retailer in the U.S. specialty retail sector and on how investors are reassessing established retail stocks in light of changing consumer habits. This...

If you are wondering whether Tetra Tech's current share price lines up with its underlying worth, this article walks through what the numbers are actually saying about value. The stock recently closed at US$27.27, with share price returns that declined 7.8% over the past week, 13.7% over the past month, 19.0% year to date and 21.9% over the past year, while the five year return sits at 18.1%. Recent headlines around Tetra Tech have kept the stock on many investors' watchlists, adding context...

Mosaic stock performance snapshot Mosaic (MOS) has seen its share price fall over the past year, with the stock down 13% over the past month and 26% over the past 3 months, closing at US$21.41 most recently. See our latest analysis for Mosaic. That recent 13% share price decline over 30 days and 26% over 3 months comes on top of a 1 year total shareholder return that is down 38%, so momentum has clearly been fading. If you are reassessing Mosaic and want to see what else is out there in...

Why Federal Realty Investment Trust (FRT) Is Back On Investor Radars Federal Realty Investment Trust (FRT) has drawn fresh attention after its recent share performance, with the stock up about 2% over the past month and roughly 8% in the past 3 months. See our latest analysis for Federal Realty Investment Trust. At a share price of $114.93, FRT has delivered a 16.06% year to date share price return and a 22.92% total shareholder return over the past year, suggesting momentum has been building...